Autonomix Medical, Inc.
NCM: AMIXLive Quote
📈 ZcoreAI Score
Our AI model analyzes Autonomix Medical, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get AMIX Z-Score →About Autonomix Medical, Inc.
Healthcare
Medical Devices
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company's technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
📊 Fundamental Analysis
Autonomix Medical, Inc. demonstrates a profit margin of 0.0%, which is below the sector average, suggesting competitive pressure.
Return on Equity (ROE) is -188.7%, which indicates that capital utilization is currently under pressure.
At a current price of $0.38, AMIX currently trades near the bottom of its 52-week range (2%), indicating potential value or weakness (Range: $0.34 - $2.82).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Return on Equity
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$4.34M
Trailing P/E
--
Forward P/E
-0.05
Beta (5Y)
-2.46
52W High
$2.82
52W Low
$0.34
Avg Volume
204K
Day High
Day Low